Issued Patents 2023
Showing 1–9 of 9 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11820997 | Methods and compositions for the targeted modification of a genome | David Frendewey, Wojtek Auerbach, Ka-Man Venus Lai, David M. Valenzuela | 2023-11-21 |
| 11778995 | Genetically modified non-human animals and methods of use thereof | Richard Flavell, Till Strowig, Markus Manz, Chiara Borsotti, Madhav Dhodapkar +2 more | 2023-10-10 |
| 11730794 | Use of a VEGF antagonist to treat angiogenic eye disorders | — | 2023-08-22 |
| 11732030 | Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments | Robert Babb, Alina BAUM, Gang Chen, Cindy Gerson, Johanna Hansen +7 more | 2023-08-22 |
| 11707506 | Use of a VEGF antagonist to treat angiogenic eye disorders | — | 2023-07-25 |
| 11697828 | Methods and compositions for targeted genetic modification using paired guide RNAs | David Frendewey, Ka-Man Venus Lai, Wojtek Auerbach, Gustavo Droguett, Anthony Gagliardi +4 more | 2023-07-11 |
| 11576356 | Genetically modified non-human animals and methods of use thereof | Dietmar Herndler-Brandstetter, Richard Flavell, Davor Frleta, Cagan Gurer, Markus Manz +6 more | 2023-02-14 |
| 11559564 | Use of a VEGF antagonist to treat angiogenic eye disorders | — | 2023-01-24 |
| 11548947 | Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof | Andrew J. Murphy, Dimitris Skokos, Janelle Waite, Erica Ullman, Aynur Hermann +2 more | 2023-01-10 |